Picture of Bionexus Gene Lab logo

BGLC Bionexus Gene Lab Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Bionexus Gene Lab, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments0.8390.6590.3660.70.579
Net Total Accounts Receivable
Net Total Receivables0.1280.0230.0164.023.44
Total Inventory
Total Other Current Assets
Total Current Assets11.30.8837.997.15
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.2730.3420.3361.851.68
Long Term Investments
Total Assets1.271.651.2310.19.57
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities1.170.0630.0523.372.33
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities1.180.130.1093.452.39
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity0.0951.521.126.667.18
Total Liabilities & Shareholders' Equity1.271.651.2310.19.57
Total Common Shares Outstanding

Or unlock with your email

Or unlock with your email